Skip to content

Clinical trials

Phase 1 Melanoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 1 Country / region: Germany Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20101
20112
20122
20135
20154
20162
20173
20181
20192
20202
20212
20222
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated11
Active, not recruiting3
Recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
Hoffmann-La Roche3
BioNTech RNA Pharmaceuticals GmbH2
Genentech, Inc.2
GlaxoSmithKline2
Amgen1
Bayer1
BioNTech SE1
Bristol-Myers Squibb1
C4 Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma34
Carcinoma, Non-Small-Cell Lung11
Colorectal Neoplasms7
Neoplasms6
Ovarian Neoplasms5
Triple Negative Breast Neoplasms5
Squamous Cell Carcinoma of Head and Neck4
Head and Neck Neoplasms3
Pancreatic Neoplasms3
Sarcoma3

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.